Société des Produits Nestlé SA engages in the manufacture and distribution of food, pharmaceutical, medical, and cosmetic products. The company was founded on December 15, 1936 and is headquartered in Vevey, France.

Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. Its products include cordycepin, metallothionein, marine elements, embryonic nutrients, and active compound of antodia cinnamomea. The company was founded on September 24, 2014 and is headquartered in Fishers, IN.

Astrego Diagnostics AB develops in vitro diagnostic products related to drug susceptibility. Its product, Captiver system, provides automated antibiotic susceptibility testing for use in patient and laboratory settings. The company was founded by Elias Amselem, Özden Baltekin, Per Ove Öhman, Mike Read, Martin Lovmar, and Per Johan Sven Elf in March 2017 and is headquartered in Uppsala, Sweden.

BioMerieux designs, develops, manufactures, and markets in vitro diagnostic systems for clinical and industrial applications. The company’s diagnostic systems consist of reagents and consumables used to conduct biological tests, for use in performing screening, diagnostic assistance, prognosis, and treatment monitoring; instruments, platforms, and autoanalyzers used for automated testing at high or low throughputs; software to process analyses and systems to interpret biological test results; and other related services such as the installation and maintenance of instruments, user training, and the audit of laboratory workflows. BioMerieux offers diagnostic systems for clinical applications including the diagnosis of infectious diseases, comprising HIV, tuberculosis, and respiratory diseases, as well as cardiovascular diseases and targeted cancers based on the analysis of biological samples such as blood, saliva, and urine; and for industrial applications including the analysis of microbiological manufacturing such as food, pharmaceuticals, and cosmetics. The company markets and sells its products through a network of distributors to private sector analysis laboratories, hospital laboratories, blood banks, and physician office laboratories; food, pharmaceutical, and cosmetics industries; and independent quality control laboratories. It has operations in Europe, the Middle East, Africa, North America, Asia-Pacific, and Latin America. BioMerieux were founded in 1963 and is headquartered in Marcy l’Etoile, France. It is a subsidiary of Institut Mérieux.

Shiseido Co., Ltd. engages in the production and sale of cosmetics for men and women. It operates through the following segments: Japan, China, Asia Pacific, Americas, Europe, Travel Retail, Professional, and Others. The Japan, China, Asia Pacific, Americas, and Europe segments sell cosmetics, fragrance, and personal care products with core brands such as Shiseido, clé de peau BEAUTÉ, ELIXIR, MAQUILLAGE, AUPRES, urara, TSUBAKI, Za, and narciso rodriguez in each corresponding region. The Travel Retail segment retails Shiseido, clé de peau BEAUTÉ, bareMinerals, and NARS brands in airport duty-free shops excluding Japan. The Professional segment manages the sale of beauty products in Japan, China, and Asia. The Others segment includes headquarter functions, production, frontier science, and restaurant businesses. The company was founded by Arinobu Fukuhara on September 17, 1872 and is headquartered in Tokyo, Japan.

Together with our partner Clinicians and Patients, we are working to bring Hair Cloning into routine clinical practice and make hair loss a thing of the past.

AID manufactures and distributes diagnostic products and imaging devices.

Stamicarbon BV engages in the design, licensing, and development of urea plants for the fertilizer industry. It offers fertilizer production, nitric acid, and emission reduction technologies. The company was founded in 1947 and is headquartered in Sittard, the Netherlands.

Spiderwort is developing a novel biomaterial that will offer new avenues in regenerative medicine. We are using plant derived cellulose to create a variety of scaffold architectures. Currently, we are in the pre-clinical stage of this product and our promising results demonstrate that this new biomaterial is highly biocompatible and induce angiogenesis (blood vessel generation inside the scaffold).

Shanghai Manyi Technology Co., Ltd., established on 2000-04-04, Business scope includes consulting services in the field of biomedicine and biological products;electronics,Communication equipment,Wholesale and retail of office supplies;Travel advisory(Do not engage in travel agency business). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Cytozyme Laboratories, Inc. supplies products and nutritional concepts for optimizing agricultural and animal production. It manufactures products for crop production, ranging from soil and seed treatments to foliar nutrient supplements to treat deficiency symptoms. The firm also manufactures specialty products designed to increase the efficiency of soil-applied fertilizers. The company’s aquaculture products offer solutions for improving soil, water and production capacities in modern, closed-system aquaculture environments. It manufactures products to improve pond environments and nutritional supplements for fish and shrimp. Cytozyme Laboratories was founded by Steve Baughman in 1975 and is headquartered in Salt Lake City, UT.

Cytyc Corporation, a diagnostic and medical device company, designs, develops, manufactures, and markets and diagnostic and surgical products. The company offers its products for a range of cancer and women's health applications, such as cervical cancer screening, menstrual bleeding treatment, early-stage breast cancer radiation treatment, and malignant brain tumors radiation treatment applications. It serves customers in the Canadian, European, and Asia/Pacific markets. The company was founded in 1987 and is based in Marlborough, Massachusetts. As of October 22, 2007, CYTYC Corporation opeartes as a subsidiary of Hologic Inc.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Nanjing Rhythm Biotechnology Co., Ltd., established on 2014-02-24, Business scope includes biotechnology research and development,transfer,consultation service;R&D of instruments and consumables,Production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanxi Qingze Environmental Technology Co., Ltd., established on 2007-08-13, Business scope includes environmental protection equipment,water treatment equipment,Dust removal equipment,Desulfurization and denitrification equipment,Electrical Equipment,Manufacture of industrial control equipment,Sales,Installation and Maintenance;Sewage Wastewater Treatment;Flue gas treatment;Rig maintenance;Communication equipment,Chemical Products(Does not contain dangerous goods),Wujinjiaodian,Mining Equipment,Equipment,building materials,water treatment agent,coal,coke,Bauxite,sales of steel;Environmental protection wind screen,sales of steel structures,Install;Environmental Engineering,Desulfurization and dust removal project,lighting project,community greening;advertising business;Leasing of environmental protection equipment;Environmental Assessment Consulting,Environmental engineering information consultation;Operation and management of environmental protection facilities;seedlings,planting of flowers,conservation,Sales;Sewage Treatment and Its Reuse;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Domestic Freight Forwarding;Loading and unloading;Activities supporting rail transport;Machinery and Equipment Leasing;Coal Washing;General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Develops and markets autologous cell-based therapeutics for use in regenerative medicine